Bruce V. Bigelow
San Diego’s Avelas Biosciences says today it has closed on $6.85 million in Series B financing to advance the use of fluorescing peptides that can be …
Bruce V. Bigelow
San Diego’s Avelas Biosciences says today it has closed on $6.85 million in Series B financing to advance the use of fluorescing peptides that can be …